Quality Management in Transfusion Medicine

Description

Transfusion Medicine is a key part of modern health care. It bridges the healthy community with the bedside in hospitals. It is the responsibility of the national blood program to provide an adequate supply of blood for all patients requiring transfusion, and to ensure the quality of blood and blood products for clinical use and the in-hospital transfusion chain. All products must be safe, clinically effective and of appropriate, and consistent quality.

Every blood transfusion service, whether serving in a resource restricted environment or in an advanced ambiance, should develop an effective quality (QS) and quality management system (QMS) to ensure the implementation of these strategies from vein to vein. The quality system and its management should cover all aspects of its activities and ensure full traceability (hemovigilance), from the motivation, mobilization and selection of blood donors to the transfusion of blood and blood products to patients. It should also reflect the structure, needs and capabilities of the procurement establishments, as well as the needs of the hospitals and patients that it serves.

Management commitment and support are essential for the development, implementation and monitoring of a national quality system and quality management system in order to ensure change management and continuous quality improvement. All staff should understand the importance of quality and the consequences of failure in the quality system (error management and cost effectiveness).

Table of Contents

Preface pp. i-x

Foreword

Chapter 1 – History of Quality Management in Transfusion Medicine
(John R. Hess, Cees Th. Smit Sibinga and Paul D. Mintz, U. of Maryland School of Medicine, Baltimore, MD, USA, and others)1-34

Chapter 2 – Need for Quality Management in Transfusion Medicine
(Jerry A. Holmberg and Neil Rosin, Novartis Vaccines and Diagnostics, Inc. Round Hill, VA, USA, and others)pp. 35-54

Chapter 3 – Quality and Quality Management Systems Applicable in Transfusion Medicine
(Cees Th. Smit Sibinga, Christian Seidl, Eduardo Nunes and James P. AuBuchon, ID Consulting for International Development of Transfusion Medicine (IDTM), University of Groningen, Groningen, NL, and others)pp. 55-130

Chapter 4 – Process Management in the Vein-to-Vein Chain
(Jan Peter Jansen van Galen and Cees Th. Smit Sibinga, Production Unit Sanquin Blood Bank, Amsterdam, NL, and others)pp. 131-186

Chapter 5 – Value and Role of Information and Communication Technology (ICT) and Management Information System (MIS) in Transfusion Medicine
(Johan A. van der Does and Thomas W. de Boer, University of Groningen, Groningen, NL, and others)pp. 187-208

Chapter 6 – Haemovigilance: Big Brother or Kindly Light?
(Lorna M. Williamson and D. Michael Strong, NHS Blood and Transplant, Watford, England, UK, and others)pp. 209-222

Chapter 7 – Event Management: A Total Organization Commitment to Quality and Safety and the Tools and Techniques Available to Achieve this Goal
(James R. Stubbs, Gwen D. Jones, Cheryl A. Nimtz and Valerie W. Halling, Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA, and others)pp. 223-262

Chapter 8 – Organizational Roles, Responsibilities and Change Management in Support of Quality Systems
(Th. Hein Smit Sibinga and Jay S. Epstein, Product Development, Constitution Medical, Inc., Boston, MA, USA, and others)pp. 263-282

Chapter 9 – Patient Safety and Quality Management at the Clinical Interface
(Michael F. Murphy, Sunita Saxena and Cees Th. Smit Sibinga, NHS Blood & Transplant and Oxford University Hospitals, Oxford, UK, and others)pp. 283-314

Chapter 10 – Quality Management at the Societal Interface
(Ton A.P.M. Los †, Sarah Mutegombwa and Che Lin Kit, APM LOS Consultancy, Groningen, The Netherlands, and others)pp. 315-356

Chapter 11 – Management of Blood Safety: Prevention and Precautions
(Elizabeth M. Dax, Alan Kitchen, Kumanan Wilson and Henk W. Reesink, The Dax Centre, University of Melbourne, Melbourne, Victoria, Australia, and others)pp. 357-384

Chapter 12 – Health Economics of Technologies in Blood Transfusion within the Context of General HTAs
(Marinus van Hulst, Maarten J, Postma and Brian Custer, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands, and others)pp. 385-412

Chapter 13 – Knowledge Management and Blood Transfusion
(René J. Jorna and Niels R. Faber, Fryske Akademy, Leeuwarden and Faculty of Economics, Business/Behavioural and Social Sciences, University of Groningen, Groningen, The Netherlands, and others)pp. 413-440

Chapter 14 – Quality Management in Transfusion Medicine in Resource Restricted Countries
(Jean C. Emmanuel, Isaac Kajja and Lawrence Marum, BTS Consultants, Harare, Zimbabwe, and others)pp. 441-456

Chapter 15 – Annexes
(Cees Th. Smit Sibinga, ID Consulting for International Development of Transfusion Medicine (IDTM), University of Groningen, Groningen, The Netherlands)pp. 457-500

Index pp. 501-518

Editors: Cees Th. Smit Sibinga (ID Consulting for International Development of Transfusion Medicine (IDTM), University of Groningen, Groningen, Netherlands)